Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $8.52, with a high ...

Teladoc (TDOC) shares are inching up after Citron Research likened them to a “coiled spring” – full of potential, compressed, and ready to surge with right catalyst – in its report on Tuesday.

Texans affected by severe flooding in central Texas can access free medical care through Teladoc Health’s Natural Disaster ...

Teladoc’s innovative platform and low 7x forward free cash flow make it an attractive opportunity despite growth risks. Learn ...

Patient safety sets the foundation for a safe, equitable, trustworthy care experience — regardless of whether you’re ...

Following a sharp rally in the previous session, Teladoc Health (NYSE:TDOC) added ~5% in the premarket on Tuesday after ...

Teladoc’s stock is down 54% this year—and 90% from its peak price in February 2021. Teladoc shares tumbled 25% after-hours Wednesday. Teladoc shares opened at $41 that morning.

Teladoc last month reported its third-quarter revenue was $522 million, an 81% increase over the third quarter of 2020. In 2022, it's expecting to bring in $2.6 billion in revenue.

Teladoc shares have fallen more than 70% so far this year after losing over half their value last year. But investors seem pleased with Teladoc's third-quarter results, as the company's shares ...

Teladoc, an embattled telehealth company, is staking its future on a new primary-care product. Called Primary360, the service is meant to stave off growing competition in telehealth. It has signed ...

Teladoc may be the best known company in the burgeoning virtual health field, which is reflected in the stock’s stunning surge this year. But it’s not the only one.